Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and mice.

scientific article

Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and mice. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.JCONREL.2011.11.022
P698PubMed publication ID22138070

P2093author name stringFrancine Behar-Cohen
Simon Benita
Faty Valamanesh
Muhammad Abdulrazik
Tal Hagigit
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectneovascularizationQ1281049
P304page(s)225-231
P577publication date2011-11-27
P1433published inJournal of Controlled ReleaseQ6295046
P1476titleOcular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: an in-vivo study in rats and mice.
P478volume160

Reverse relations

cites work (P2860)
Q38196447Dendrimers for gene delivery--a potential approach for ocular therapy?
Q53749395Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle.
Q36852078Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation
Q36228393Modification of palm kernel oil esters nanoemulsions with hydrocolloid gum for enhanced topical delivery of ibuprofen
Q58716234Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application
Q36024067Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera
Q38196446Topical delivery of ocular therapeutics: carrier systems and physical methods.

Search more.